Related Experiment Video
Updated: Mar 17, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
25.2K
Major milestones in translational oncology
Tommaso A Dragani1, Antoni Castells2, Vathany Kulasingam3,4
1Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo 42, I-20133, Milan, Italy. tommaso.dragani@istitutotumori.mi.it.
BMC Medicine
|July 30, 2016
Summary
Translational oncology advances cancer care by integrating genomic insights into clinical practice. Personalized therapies are crucial due to complex cancer genetics and tumor mutations.
Area of Science:
- Oncology
- Genomics
- Cancer Medicine
Background:
- Translational oncology bridges basic science and clinical practice.
- Genome-scale studies provide extensive knowledge of tumorigenesis pathways.
- This article reviews the state of the art in translational oncology across five major cancer types.
Discussion:
- Molecular profiling aids colorectal cancer subtyping for diagnosis and treatment.
- Nationwide ovarian cancer screening utilizes serum tumor biomarker detection.
- Circulating tumor DNA monitoring offers a safe approach for breast cancer treatment management.
- Immune checkpoint inhibitors show efficacy in advanced lung cancer.
- Prostate cancer biopsy molecular profiling supports treatment decisions.
Key Insights:
- Molecular subtyping and biomarker detection are key for diagnosis and treatment.
- Liquid biopsies (circulating tumor DNA) enable safe treatment monitoring.
- Targeted therapies, including immune checkpoint inhibitors, are effective in specific cancers.
- Personalized therapies are essential given cancer's genetic complexity.
Outlook:
- Continued integration of molecular profiling into clinical decision-making.
- Development of personalized therapies tailored to individual genetic profiles.
- Addressing the challenges posed by complex cancer genetics and somatic mutations.
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
03:03mTOR Signaling and Cancer Progression
1.6K
1.6K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
02:07Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
02:07Tumor Progression
3.5K
3.5K